menu
    • menu

    Company profile for Cipla

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cipla is a global pharmaceutical company whose goal is ensuring no patient shall be denied access to high quality & affordable medicine and support. Mission: Cipla’s mission is to be a leading global healthcare company which uses technology and innovation to meet everyday needs of all patients. Since inception in 1935, caring has been at the core of everything we do at Cipla. For patients, caring is a promise that we...
    Cipla is a global pharmaceutical company whose goal is ensuring no patient shall be denied access to high quality & affordable medicine and support. Mission: Cipla’s mission is to be a leading global healthcare company which uses technology and innovation to meet everyday needs of all patients. Since inception in 1935, caring has been at the core of everything we do at Cipla. For patients, caring is a promise that we will do whatever it takes to ensure they have continued access to the highest quality medicines at affordable prices; whether a disease affects millions or just a few hundreds.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ciplaindia-flag Flag
    Country
    Country
    India
    Address
    Address
    Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumba...
    Telephone
    Telephone
    +91 22 23082891 / 23095521
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cipla.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI India

    Not Confirmed

    envelop Contact Supplier

    CPhI India

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “We’re expanding our CDMO capabilities to meet the next wave of complex therapies, starting with oncology.”

    mic“We’re expanding our CDMO capabilities to meet the next wave of complex therapies, starting with oncology.”

    This week, SpeakPharma interviews Dr. Abdelaziz Toumi, Chief Executive Officer of Lupin Manufacturing Solutions (LMS). With over two decades of global leadership experience in the pharmaceutical and manufacturing sectors, Dr. Toumi has been instrumental in shaping LMS’s transformation into a science-driven, client-centric CDMO. Under his leadership, LMS has expanded into complex APIs, oncology manufacturing, and sustainability-led operations. In this exclusive interview with PharmaCompass, Dr. Toumi shares how the company is reshaping its CDMO strategy to serve the evolving needs of global pharma and biotech clients. He also talks about LMS’s latest milestone — the commissioning of a new dedicated oncology block at its Vizag site as the company strengthens its position in high-potency and complex API development ahead of CPHI Frankfurt. Dr. Abdelaziz, Lupin Manufacturing Solutions has been gaining visibility lately. For those who might not be familiar, how would you describe LMS and its vision within the Lupin Group? LMS represents Lupin’s commitment to extending its scientific excellence and manufacturing quality into the CDMO space. LMS was created with a clear vision to collaborate with innovators, biotech firms, and pharmaceutical companies to accelerate their molecules from development to commercial scale, with the assurance of Lupin’s global quality and compliance standards. In essence, LMS blends Lupin’s heritage of trust with the flexibility and customer-focus of a pure-play CDMO. That’s our DNA. HIGHLIGHTS// Extending scientific excellence to CDMO/assurance of global quality, compliance standards/blending heritage of trust with flexibility, customer focus What makes LMS different in an increasingly competitive global CDMO market? The CDMO industry today is not about who has the largest capacity. Rather, it’s about who brings the most value, scientific innovation and speed to the table. Our edge lies in complex chemistry capabilities, deep regulatory expertise, and a culture built around collaboration and accountability. We focus on areas where precision and containment matter, including highly potent APIs (HPAPIs), oncology, and niche small molecules, and we back that up with teams who think beyond manufacturing, toward solving our clients’ development and commercialization challenges. HIGHLIGHTS// Complex chemistry capabilities/deep regulatory expertise/culture built around collaboration and accountability Dr. Abdelaziz, you mentioned oncology as a key focus area. Can you share more about LMS’s plans in this space? Yes, and I am happy to share this first with PharmaCompass — that we have just commissioned our new oncology block at our Vizag site, which is now operationally ready. This is a major step forward for LMS. The facility has been purpose-built for HPAPIs and oncology APIs, and is equipped with advanced containment systems, over 20 reactors and more than 20 isolators. It has a team of over 100 highly skilled scientists specializing in complex and hazardous chemistries. It expands both our capacity and our confidence to support partners in developing targeted cancer therapies. More importantly, it signals our intent — that we are serious about being a global partner of choice in the oncology CDMO space. HIGHLIGHTS// Commissioned new oncology block at Vizag/facility built for HPAPIs, oncology APIs/equipped with advanced containment systems/100 skilled scientists That’s an exciting development. What opportunities do you see in the oncology manufacturing segment globally? The oncology segment is transforming the pharmaceutical landscape. Globally, it is one of the segments with the highest number of development drugs in the pipeline. With the rise of targeted therapies, potent compounds, and smaller-volume high-value APIs, clients are looking for CDMO partners who combine containment expertise with speed and reliability. We see a strong opportunity here, especially as innovators look to move from lab to commercial scale faster, without compromising safety or compliance. LMS is stepping into this gap with the right infrastructure, people, and mindset to deliver. HIGHLIGHTS// Oncology transforming pharmaceutical landscape/highest number of drugs in pipeline/clients looking for CDMOs in oncology space CPHI Frankfurt is around the corner. What can we expect from LMS this year? This CPHI will be a defining one for us. We will be showcasing LMS as a comprehensive small-molecule CDMO, with a sharpened focus on high-potency and oncology manufacturing. Our conversations in Frankfurt will center around how we can help clients navigate development complexity with the confidence of partnering with a science-first, quality-driven CDMO. People will see a refreshed LMS — one that’s growing fast, innovating continuously, and thinking globally. HIGHLIGHTS// Frankfurt CPHI to be a defining one for LMS/helping clients navigate development complexity with confidence/science-first, quality-driven CDMO Quality and sustainability are gaining importance in CDMO partnerships. How is LMS addressing these dimensions? For us, quality and sustainability are a part of our culture. Every process at LMS is anchored in patient safety, compliance, and continuous improvement. Our regulatory systems are built on Lupin’s decades of global experience, and we are leveraging that legacy in every project we take on. On sustainability, we are investing in green chemistry principles, waste minimization, and energy-efficient operations. We believe responsible manufacturing is not just an ESG statement; it’s good business and essential for long-term trust. HIGHLIGHTS// Quality, sustainability part of culture/processes anchored in patient safety, compliance/regulatory systems built on decades of global experience/investing in sustainability Partnership seems to be a recurring theme for LMS. How do you define a true CDMO partnership? A real partnership starts with shared ambition. We see ourselves not just as a manufacturer, but as an innovation partner working as an extension of our client’s R&D and operations teams. The most successful projects we have delivered are those where we have been involved early, and those that align us on the development strategy, risk management, and commercial readiness. That is what we mean when we say we are building science-led partnerships — these are partnerships that are collaborative, transparent, and outcome-driven. HIGHLIGHTS// Innovation partner working as an extension of clients’ R&D, ops team/need to involve LMS early for successful projects/building science-led partnerships Finally, what is next for LMS as you look beyond this milestone? The oncology block is just the beginning of a larger journey. We are scaling our analytical and development services, peptide synthesis capabilities, adding bioconjugation services, expanding global business development, and investing in digital and automation initiatives to make project execution even more seamless. Our goal is to evolve into a trusted global CDMO partner that combines Lupin’s credibility with next-generation manufacturing and scientific agility. As I like to say – we are not just manufacturing APIs; we are manufacturing trust, innovation, and long-term partnerships. HIGHLIGHTS// Scaling analytical, development services, peptide synthesis capabilities/adding bioconjugation services/expanding global business/investing in digital initiatives 

    Impressions: 1053

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/we-re-expanding-our-cdmo-capabilities-to-meet-the-next-wave-of-complex-therapies-starting-with-oncology

    PharmaCompass
    22 Oct 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaPartner in End-to-End API ManufacturingPartner in End-to-End API Manufacturing

    Partner in End-to-End API Manufacturing
    Partner in End-to-End API Manufacturing

    reelPartner in End-to-End API Manufacturing

    This PharmaReel showcases Coral Drugs, a global partner in end-to-end API manufacturing with more than 27 years of expertise. Supported by vertically integrated cGMP and ISO-compliant facilities, the company is backed by USFDA and EMA certifications, patents, and advanced micronization capabilities.

    Impressions: 3480

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    CDMO Activity Tracker: Veranova, ChemExpress invest in ADC facilities; Cohance to set up oligonucleotide facility in India

    CDMO Activity Tracker: Veranova, ChemExpress invest in ADC facilities; Cohance to set up oligonucleotide facility in India

    The contract development and manufacturing organization (CDMO) sector has emerged as a key partner in new drug development. This was evident from the strategic investments, partnerships, and expansions witnessed in the third quarter (Q3) of 2025. Several CDMOs, such as Cohance Lifesciences, Fermion Oy, Axplora, AGC Pharma Chemicals invested in new projects. Others, including Veranova, Aenova, and Biosynth, expanded capacities, while Ofichem strengthened its footprint with the acquisition of Avivia BV. CDMOs like Fareva, Evonik, and Samsung Biologics forged strategic partnerships for growth. During Q3, the sector continued to adopt artificial intelligence (AI). This prompted the US Food and Drug Administration (FDA) to issue guidance that recognizes the increasing use of AI and data analytics in drug development.  View CDMO Activity Tracker for Q3 2025 (Free Excel Available) Cohance, Veranova invest in bioconjugation suites in US; ChemExpress inks ADC deal Earlier this year, Indian drugmaker Suven Pharmaceuticals Limited merged with  leading CDMO Cohance Lifesciences Limited. The merged entity — Cohance Lifesciences — has invested US$ 10 million in a current Good Manufacturing Practice (cGMP) bioconjugation suite at its subsidiary NJ Bio in Princeton, New Jersey.  NJ Bio is executing a major program for an existing innovator client with multiple antibody-drug conjugate (ADC) candidates. Cohance also announced an INR 230 million (approximately US$ 2.58 million) investment in a cGMP oligonucleotide facility at its Hyderabad (India) site. Veranova’s Devens (Massachusetts) site successfully passed a routine FDA cGMP surveillance inspection with a “No Action Indicated” (NAI) classification. Earlier, the company had initiated a US$ 50 million investment to expand its ADC and bioconjugate capabilities at its Devens site. This includes a 9,000-square-foot facility expansion with a new process development lab, two additional cGMP suites, and state-of-the-art bioconjugation development and manufacturing capabilities. These initiatives strengthen the site’s highly potent API (HPAPI) and ADC development and manufacturing capabilities. Biosynth has expanded its Berlin facility with a new GMP bioconjugation suite. The expansion supports the company’s manufacturing capabilities in conjugate vaccines, conjugate drugs, activated polyethylene glycol (PEGs), and polymer-based drug delivery excipients. ChemExpress, Mabwell Bioscience, and Insilico Medicine have entered into a strategic partnership to jointly develop a large ADC compound library and advance next-generation ADC candidates. The collaboration combines Mabwell’s antibody and ADC technology, Insilico’s AI-powered drug design platform, and ChemExpress’s expertise in linker-payload chemistry. Together, they aim to build a complete, AI-driven ADC development model that accelerates discovery, optimization, and commercialization. This partnership is expected to enhance R&D efficiency and deliver safer, more effective cancer treatments.  View CDMO Activity Tracker for Q3 2025 (Free Excel Available) Fermion, Axplora, Aenova increase API manufacturing capacities; ICE Pharma expands India facility Finnish CDMO Fermion Oy has launched a renovation project at its Hanko (Finland) production site to modernize its API manufacturing capabilities. This expansion is part of Fermion's broader strategy to increase production, enhance flexibility in the manufacturing of both existing and future pharmaceutical products, and enable potential contract manufacturing opportunities. German CDMO Axplora has announced a €6.5 million (approximately US$ 7.5 million) investment to expand its API manufacturing capacity at its Vizag site in India. This expansion aims to strengthen both production capabilities and supply chain resilience. India-based Aarti Pharmalabs has inaugurated the first phase of its greenfield manufacturing facility in Gujarat (India). This expansion aims to bolster Aarti's CDMO and contract manufacturing organization (CMO) services, targeting a revenue goal of INR 10 billion (approximately US$ 112 million). Snapdragon Chemistry, which was acquired by Cambrex in 2023, has expanded its Massachusetts facility to better support peptide drug development and manufacturing. With this upgrade, the company can now handle peptide projects from early development through full-scale manufacturing. Italy-headquartered ICE Pharma has expanded its Raichem facility in India. The new facility will enhance the production of ursodeoxycholic acid (UDCA), an API it derives from chicken bile. This expansion increases the site’s raw UDCA output by 120 metric tons annually. Spain-headquartered AGC Pharma Chemicals inaugurated a new advanced manufacturing plant in Barcelona, with an investment of €110 million (approximately US$ 128.3 million). The plant spans 7,500 square meters and integrates cutting-edge technologies to support the entire drug development lifecycle — from R&D to commercial manufacturing. This represents a 30 percent increase in the company’s production capacity and introduces a segment dedicated to HPAPIs. Germany-headquartered Aenova has launched a new hot melt extrusion platform at its Regensburg (Germany) site. This new equipment enables the production of advanced drug formulations, while handling all testing and quality checks in-house. The move strengthens Aenova’s capabilities in developing and manufacturing complex medications. US-based Cytovance Biologics has introduced in-house formulation development services, enhancing its role as a comprehensive partner for biologic drug developers. These services utilize quality-by-design principles to ensure speed, safety, and precision in current and future client programs.  View CDMO Activity Tracker for Q3 2025 (Free Excel Available)  Ofichem acquires Avivia BV; Evonik, Samsung Biologics form strategic collaborations Europe-based CDMO Ofichem Group announced the acquisition of Avivia BV, a formulation development company in the Netherlands. This acquisition is part of Ofichem’s strategy to become a fully integrated provider of development solutions across both drug substance and drug product, with a focus on complex formulations. Ofichem has also acquired Meribel Pharma Solutions’ site in Uppsala (Sweden) to strengthen its support for biotech innovators and expand its presence in the Nordic region.  Simtra BioPharma Solutions has acquired a 65-acre property near its Bloomington, Indiana (US) facility, adding over 300,000 square feet of potential expansion space. With this site, Simtra now has the flexibility to rapidly expand in the US. German specialty chemicals company Evonik is partnering with German biotech Ethris to develop and commercialize a next-generation lipid nanoparticle (LNP) platform for delivering nucleic acid therapies. Evonik will assist in formulation using Ethris’ SNaP LNP technology. The LNP market alone is projected to grow to US$2.3 billion by 2032. Luxembourg-headquartered Fareva has partnered with Zhaoke Ophthalmology to expand its footprint in China’s pharma market. Zhaoke will act as Fareva’s go-to partner for customers seeking pharmaceutical manufacturing in China. Samsung Biologics has signed a 1.8 trillion won (US$ 1.3 billion) manufacturing agreement with an undisclosed US-based drugmaker. And UK-based eXmoor Pharma has partnered with Anthony Nolan to provide end-to-end services for cell therapy developers.  View CDMO Activity Tracker for Q3 2025 (Free Excel Available)  Our view The global CDMO market, valued at around US$ 255 billion in 2025, is projected to grow to over US$ 465 billion by 2032. Significantly, about 60 percent of new drug approvals in the US and over 65 percent in Europe now involve CDMO support. The developments outlined above underscore the increasing role CDMOs are playing today in bringing about growth and innovation in the pharmaceutical industry.  
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 1680

    https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india

    #PharmaFlow by PHARMACOMPASS
    16 Oct 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Cipla To Fully Acquire Inzpera Healthscience
    Cipla To Fully Acquire Inzpera Healthscience

    04 Nov 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-to-fully-acquire-inzpera-healthscience/articleshow/125061279.cms

    ECONOMICTIMES
    04 Nov 2025
    Share Share
    Cipla Posts Consolidated Q2 FY26 PAT Rs. 1,351.17 Cr
    Cipla Posts Consolidated Q2 FY26 PAT Rs. 1,351.17 Cr

    02 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/cipla-posts-consolidated-q2-fy26-pat-rs-135117-cr-18131

    INDPHARMAPOST
    02 Nov 2025
    Share Share
    Cipla Names Achin Gupta As MD & GCEO Effective April 1, 2026
    Cipla Names Achin Gupta As MD & GCEO Effective April 1, 2026

    30 Oct 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/cipla-names-achin-gupta-as-md-gceo-effective-april-1-2026/

    EXPRESSPHARMA
    30 Oct 2025
    Share Share
    Stempeutics Anticipates Japan Approval For Stem Cell Therapy
    Stempeutics Anticipates Japan Approval For Stem Cell Therapy

    29 Oct 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/stempeutics-expecting-japan-approval-for-its-stem-cell-therapy-by-2029/articleshow/124892849.cms

    ECONOMICTIMES
    29 Oct 2025
    Share Share
    Lilly, Cipla Partner For Yurpeak Distribution In Weight Loss Drug
    Lilly, Cipla Partner For Yurpeak Distribution In Weight Loss Drug

    23 Oct 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lilly-cipla-ink-distribution-pact-for-weight-loss-type-2-diabetes-treatment-drug-yurpeak/articleshow/124765317.cms

    ECONOMICTIMES
    23 Oct 2025
    Share Share
    Cipla’s Generics Bictegravir Receives Tentative Approval in US
    Cipla’s Generics Bictegravir Receives Tentative Approval in US

    14 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218766

    FDA
    14 Oct 2025
    Share Share

    Drugs in Development

    read-more
    read-more
    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lilly, Cipla Sign Pact for Weight Loss, Type 2 Diabetes Drug Yurpeak

    Details:

    The partnership with Tirzepatide aims to advance the clinical development of the peptide in type 2 diabetes by targeting GLP-1 and GIP receptors.


    Lead Product(s): Tirzepatide,Inapplicable

    Therapeutic Area: Endocrinology Brand Name: Yurpeak

    Study Phase: Approved FDFProduct Type: Peptide, Unconjugated

    Sponsor: Eli Lilly

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Partnership October 23, 2025

    blank

    01

    Cipla

    India
    arrow
    AIChE Annual Meeting
    Not Confirmed

    Cipla

    India
    arrow
    AIChE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Tirzepatide,Inapplicable

    Therapeutic Area : Endocrinology

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Eli Lilly

    Deal Size : Undisclosed

    Deal Type : Partnership

    DEALS_DEV arrow-down

    Lilly, Cipla Sign Pact for Weight Loss, Type 2 Diabetes Drug Yurpeak

    Details : The partnership with Tirzepatide aims to advance the clinical development of the peptide in type 2 diabetes by targeting GLP-1 and GIP receptors.

    Product Name : Yurpeak

    Product Type : Peptide, Unconjugated

    Upfront Cash : Undisclosed

    October 23, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Cipla Launches ZEMDRI (Plazomicin) in India, Aims to Tackle AMR

    Details:

    Zemdri (plazomicin), a novel treatment for complicated Urinary Tract Infections (cUTI), including pyelonephritis is launched in India.


    Lead Product(s): Plazomicin,Inapplicable

    Therapeutic Area: Infections and Infectious Diseases Brand Name: Zemdri

    Study Phase: Approved FDFProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable May 21, 2025

    blank

    02

    Cipla

    India
    arrow
    AIChE Annual Meeting
    Not Confirmed

    Cipla

    India
    arrow
    AIChE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Plazomicin,Inapplicable

    Therapeutic Area : Infections and Infectious Diseases

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Cipla Launches ZEMDRI (Plazomicin) in India, Aims to Tackle AMR

    Details : Zemdri (plazomicin), a novel treatment for complicated Urinary Tract Infections (cUTI), including pyelonephritis is launched in India.

    Product Name : Zemdri

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    May 21, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Cipla Receives US FDA Approval for Generic Version of Abraxane

    Details:

    Paclitaxel is a microtubule inhibitor indicated for metastatic breast cancer, locally advanced or metastatic non-small cell lung cancer & metastatic pancreatic adenocarcinoma.


    Lead Product(s): Paclitaxel,Inapplicable

    Therapeutic Area: Oncology Brand Name: Abraxane-Generic

    Study Phase: Approved FDFProduct Type: Cytotoxic Drug

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable April 11, 2025

    blank

    03

    Cipla

    India
    arrow
    AIChE Annual Meeting
    Not Confirmed

    Cipla

    India
    arrow
    AIChE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Paclitaxel,Inapplicable

    Therapeutic Area : Oncology

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Cipla Receives US FDA Approval for Generic Version of Abraxane

    Details : Paclitaxel is a microtubule inhibitor indicated for metastatic breast cancer, locally advanced or metastatic non-small cell lung cancer & metastatic pancreatic adenocarcinoma.

    Product Name : Abraxane-Generic

    Product Type : Cytotoxic Drug

    Upfront Cash : Inapplicable

    April 11, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Cipla and Formosa Sign Multi-Regional Licensing Deal for Clobetasol Suspension

    Details:

    Cipla has rights to market the innovative treatment, APP13007, a novel, patent protected and USFDA approved ophthalmic product, for post-operative inflammation and pain following ocular surgery.


    Lead Product(s): Clobetasol Propionate,Inapplicable

    Therapeutic Area: Neurology Brand Name: Undisclosed

    Study Phase: Approved FDFProduct Type: Steroid

    Recipient: Formosa Pharmaceuticals

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Licensing Agreement March 18, 2025

    blank

    04

    Cipla

    India
    arrow
    AIChE Annual Meeting
    Not Confirmed

    Cipla

    India
    arrow
    AIChE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Clobetasol Propionate,Inapplicable

    Therapeutic Area : Neurology

    Highest Development Status : Approved FDF

    Recipient : Formosa Pharmaceuticals

    Deal Size : Undisclosed

    Deal Type : Licensing Agreement

    DEALS_DEV arrow-down

    Cipla and Formosa Sign Multi-Regional Licensing Deal for Clobetasol Suspension

    Details : Cipla has rights to market the innovative treatment, APP13007, a novel, patent protected and USFDA approved ophthalmic product, for post-operative inflammation and pain following ocular surgery.

    Product Name : Undisclosed

    Product Type : Steroid

    Upfront Cash : Undisclosed

    March 18, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Cipla Gets CDSCO Nod to Launch Inhalation Insulin

    Details:

    Afrezza (human Insulin) is the only ultra rapid-acting inhaled insulin that act as Insulin receptor agonist, indicated for the treatment of diabetes.


    Lead Product(s): Technosphere Insulin,Insulin,Inapplicable

    Therapeutic Area: Endocrinology Brand Name: Afrezza

    Study Phase: Approved FDFProduct Type: Hormone

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable December 11, 2024

    blank

    05

    Cipla

    India
    arrow
    AIChE Annual Meeting
    Not Confirmed

    Cipla

    India
    arrow
    AIChE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Technosphere Insulin,Insulin,Inapplicable

    Therapeutic Area : Endocrinology

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Cipla Gets CDSCO Nod to Launch Inhalation Insulin

    Details : Afrezza (human Insulin) is the only ultra rapid-acting inhaled insulin that act as Insulin receptor agonist, indicated for the treatment of diabetes.

    Product Name : Afrezza

    Product Type : Hormone

    Upfront Cash : Inapplicable

    December 11, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV

    Details:

    Pramipexole is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Depressive Disorder, Major.


    Lead Product(s): Pramipexole Dihydrochloride,Inapplicable

    Therapeutic Area: Psychiatry/Psychology Brand Name: Undisclosed

    Study Phase: Phase IIProduct Type: Miscellaneous

    Recipient: National Institute of Allergy and Infectious Diseases

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable November 26, 2024

    blank

    06

    Cipla

    India
    arrow
    AIChE Annual Meeting
    Not Confirmed

    Cipla

    India
    arrow
    AIChE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Pramipexole Dihydrochloride,Inapplicable

    Therapeutic Area : Psychiatry/Psychology

    Highest Development Status : Phase II

    Recipient : National Institute of Allergy and Infectious Diseases

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mil...

    Details : Pramipexole is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Depressive Disorder, Major.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    November 26, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Orchid Pharma and Cipla collaborate to launch antibiotic Cefepime-Enmetazobactam in India

    Details:

    Through the collaboration Orchid & Cipla will launch Exblifep (cefepime/enmetazobactam), which is indicated for the treatment of complicated urinary tract infections, including pyelonephritis.


    Lead Product(s): Cefepime,Enmetazobactam

    Therapeutic Area: Infections and Infectious Diseases Brand Name: Exblifep

    Study Phase: Approved FDFProduct Type: Antibiotic

    Recipient: Orchid Pharma

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Collaboration June 29, 2024

    blank

    07

    Cipla

    India
    arrow
    AIChE Annual Meeting
    Not Confirmed

    Cipla

    India
    arrow
    AIChE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Cefepime,Enmetazobactam

    Therapeutic Area : Infections and Infectious Diseases

    Highest Development Status : Approved FDF

    Recipient : Orchid Pharma

    Deal Size : Undisclosed

    Deal Type : Collaboration

    DEALS_DEV arrow-down

    Orchid Pharma and Cipla collaborate to launch antibiotic Cefepime-Enmetazobactam in India

    Details : Through the collaboration Orchid & Cipla will launch Exblifep (cefepime/enmetazobactam), which is indicated for the treatment of complicated urinary tract infections, including pyelonephritis.

    Product Name : Exblifep

    Product Type : Antibiotic

    Upfront Cash : Undisclosed

    June 29, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Cipla Signs Agreement With Takeda To Commercialize Vonoprazan in India

    Details:

    Under the terms of this agreement, Takeda has granted Cipla non-exclusive patent licensing rights for the commercialization of Voltapraz (vonoprazan) in India.


    Lead Product(s): Vonoprazan Fumarate,Inapplicable

    Therapeutic Area: Gastroenterology Brand Name: Voltapraz

    Study Phase: Approved FDFProduct Type: Miscellaneous

    Recipient: Takeda Pharmaceutical

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Licensing Agreement June 20, 2024

    blank

    08

    Cipla

    India
    arrow
    AIChE Annual Meeting
    Not Confirmed

    Cipla

    India
    arrow
    AIChE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Vonoprazan Fumarate,Inapplicable

    Therapeutic Area : Gastroenterology

    Highest Development Status : Approved FDF

    Recipient : Takeda Pharmaceutical

    Deal Size : Undisclosed

    Deal Type : Licensing Agreement

    DEALS_DEV arrow-down

    Cipla Signs Agreement With Takeda To Commercialize Vonoprazan in India

    Details : Under the terms of this agreement, Takeda has granted Cipla non-exclusive patent licensing rights for the commercialization of Voltapraz (vonoprazan) in India.

    Product Name : Voltapraz

    Product Type : Miscellaneous

    Upfront Cash : Undisclosed

    June 20, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Cipla Gets Approval for Generic Somatuline® Depot Injection (Lanreotide)

    Details:

    Lanreotide generic injection is approved by FDA for the treatment of patients with Acromegaly and Gastroenteropancreatic Neuroendocrine Tumors.


    Lead Product(s): Lanreotide Acetate,Inapplicable

    Therapeutic Area: Endocrinology Brand Name: Somatuline Depot-Generic

    Study Phase: Approved FDFProduct Type: Peptide, Unconjugated

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable May 22, 2024

    blank

    09

    Cipla

    India
    arrow
    AIChE Annual Meeting
    Not Confirmed

    Cipla

    India
    arrow
    AIChE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Lanreotide Acetate,Inapplicable

    Therapeutic Area : Endocrinology

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Cipla Gets Approval for Generic Somatuline® Depot Injection (Lanreotide)

    Details : Lanreotide generic injection is approved by FDA for the treatment of patients with Acromegaly and Gastroenteropancreatic Neuroendocrine Tumors.

    Product Name : Somatuline Depot-Generic

    Product Type : Peptide, Unconjugated

    Upfront Cash : Inapplicable

    May 22, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India

    Details:

    Insulin Lispro is a Peptide drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Diabetes Mellitus, Type 2.


    Lead Product(s): Insulin Lispro,Insulin Glargine

    Therapeutic Area: Endocrinology Brand Name: Undisclosed

    Study Phase: Phase IVProduct Type: Peptide, Unconjugated

    Recipient: Eli Lilly

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable April 17, 2024

    blank

    10

    Cipla

    India
    arrow
    AIChE Annual Meeting
    Not Confirmed

    Cipla

    India
    arrow
    AIChE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Insulin Lispro,Insulin Glargine

    Therapeutic Area : Endocrinology

    Highest Development Status : Phase IV

    Recipient : Eli Lilly

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India

    Details : Insulin Lispro is a Peptide drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Diabetes Mellitus, Type 2.

    Product Name : Undisclosed

    Product Type : Peptide, Unconjugated

    Upfront Cash : Inapplicable

    April 17, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact CIPLA LTD and get a quotation

    CIPLA LTD is a supplier offers 334 products (APIs, Excipients or Intermediates).

    Find a price of Amlodipine Besylate bulk with DMF, CEP, JDMF, WC offered by CIPLA LTD

    Find a price of Celecoxib bulk with DMF, CEP, JDMF, WC offered by CIPLA LTD

    Find a price of Etoposide bulk with DMF, CEP, JDMF, WC offered by CIPLA LTD

    Find a price of Abacavir Sulfate bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Alendronate Sodium bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Bicalutamide bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Budesonide bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Cetirizine Dihydrochloride bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Efinaconazole bulk with DMF, JDMF, WC offered by CIPLA LTD

    Find a price of Escitalopram Oxalate bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Esomeprazole Magnesium bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Exemestane bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Felodipine bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Finasteride bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Fluticasone Propionate bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Formoterol Fumarate bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Gefitinib bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Granisetron Hydrochloride bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Imatinib Mesylate bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Lamivudine bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Lamotrigine bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Leflunomide bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Letrozole bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Meloxicam bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Omeprazole bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Ondansetron Hydrochloride bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Oseltamivir Phosphate bulk with DMF, JDMF, WC offered by CIPLA LTD

    Find a price of Pantoprazole Sodium bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Pirfenidone bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Praziquantel bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Ramipril bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Risedronate Sodium bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Risperidone bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Rivastigmine Tartrate bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Salbutamol Sulphate bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Solifenacin Succinate bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Terbinafine Hydrochloride bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Trimetazidine Hydrochloride bulk with DMF, CEP, WC offered by CIPLA LTD

    Find a price of Abiraterone Acetate bulk with JDMF, WC offered by CIPLA LTD

    Find a price of Beclomethasone Dipropionate bulk with CEP, WC offered by CIPLA LTD

    Find a price of Carvedilol bulk with CEP, WC offered by CIPLA LTD

    Find a price of Citalopram Hydrobromide bulk with CEP, WC offered by CIPLA LTD

    Find a price of Cyproterone Acetate bulk with CEP, WC offered by CIPLA LTD

    Find a price of Desloratadine bulk with CEP, WC offered by CIPLA LTD

    Find a price of Fluconazole bulk with CEP, WC offered by CIPLA LTD

    Find a price of Mometasone Furoate bulk with CEP, WC offered by CIPLA LTD

    Find a price of Nevirapine bulk with DMF, WC offered by CIPLA LTD

    Find a price of Omeprazole Sodium bulk with CEP, WC offered by CIPLA LTD

    Find a price of Pramipexole Dihydrochloride bulk with CEP, WC offered by CIPLA LTD

    Find a price of Salbutamol Sulphate bulk with CEP, WC offered by CIPLA LTD

    Find a price of Salmeterol Xinafoate bulk with CEP, WC offered by CIPLA LTD

    Find a price of Tamsulosin bulk with CEP, WC offered by CIPLA LTD

    Find a price of Venlafaxine Hydrochloride bulk with CEP, WC offered by CIPLA LTD

    Find a price of Ambrisentan bulk with DMF, WC offered by CIPLA LTD

    Find a price of Amlodipine Besylate bulk with CEP, WC offered by CIPLA LTD

    Find a price of Anastrozole bulk with DMF, CEP offered by CIPLA LTD

    Find a price of Apremilast bulk with DMF, WC offered by CIPLA LTD

    Find a price of Arformoterol Tartrate bulk with DMF, WC offered by CIPLA LTD

    Find a price of Beclomethasone Dipropionate bulk with DMF, WC offered by CIPLA LTD

    Find a price of Bosentan Hydrate bulk with DMF, WC offered by CIPLA LTD

    Find a price of Ciclesonide bulk with CEP, WC offered by CIPLA LTD

    Find a price of Cinacalcet Hydrochloride bulk with DMF, WC offered by CIPLA LTD

    Find a price of Danazol bulk with DMF, WC offered by CIPLA LTD

    Find a price of Darifenacin Hydrobromide bulk with DMF, WC offered by CIPLA LTD

    Find a price of Darunavir bulk with DMF, WC offered by CIPLA LTD

    Find a price of Darunavir Ethanolate bulk with DMF, WC offered by CIPLA LTD

    Find a price of Deferasirox bulk with DMF, WC offered by CIPLA LTD

    Find a price of Dolutegravir Sodium bulk with DMF, WC offered by CIPLA LTD

    Find a price of Efavirenz bulk with DMF, WC offered by CIPLA LTD

    Find a price of Eliglustat bulk with DMF, WC offered by CIPLA LTD

    Find a price of Empagliflozin bulk with DMF, WC offered by CIPLA LTD

    Find a price of Emtricitabine bulk with DMF, WC offered by CIPLA LTD

    Find a price of Entecavir bulk with DMF, CEP offered by CIPLA LTD

    Find a price of Erlotinib Hydrochloride bulk with DMF, WC offered by CIPLA LTD

    Find a price of Escitalopram Oxalate bulk with DMF, CEP offered by CIPLA LTD

    Find a price of Famciclovir bulk with DMF, WC offered by CIPLA LTD

    Find a price of Finasteride bulk with WC offered by CIPLA LTD

    Find a price of Fluticasone Propionate bulk with DMF, CEP offered by CIPLA LTD

    Find a price of Granisetron bulk with DMF, WC offered by CIPLA LTD

    Find a price of Lenalidomide bulk with DMF, WC offered by CIPLA LTD

    Find a price of Levocetirizine Dihydrochloride bulk with DMF, WC offered by CIPLA LTD

    Find a price of Mebendazole bulk with DMF, WC offered by CIPLA LTD

    Find a price of Nintedanib Esylate bulk with DMF, WC offered by CIPLA LTD

    Find a price of Olanzapine bulk with WC offered by CIPLA LTD

    Find a price of Omeprazole bulk with DMF, WC offered by CIPLA LTD

    Find a price of Palonosetron bulk with DMF, WC offered by CIPLA LTD

    Find a price of Pazopanib Hydrochloride bulk with DMF, WC offered by CIPLA LTD

    Find a price of Ritonavir bulk with DMF, WC offered by CIPLA LTD

    Find a price of Rivaroxaban bulk with DMF, CEP offered by CIPLA LTD

    Find a price of Rizatriptan Benzoate bulk with WC offered by CIPLA LTD

    Find a price of Salbutamol Sulphate bulk with DMF, CEP offered by CIPLA LTD

    Find a price of Tenofovir Alafenamide Fumarate bulk with DMF, WC offered by CIPLA LTD

    Find a price of Tenofovir Disoproxil Fumarate bulk with DMF, WC offered by CIPLA LTD

    Find a price of Tiotropium Bromide bulk with CEP, WC offered by CIPLA LTD

    Find a price of Topiramate bulk with DMF, WC offered by CIPLA LTD

    Find a price of Valacyclovir Hydrochloride bulk with DMF, WC offered by CIPLA LTD

    Find a price of Valganciclovir Hydrochloride bulk with DMF, WC offered by CIPLA LTD

    Find a price of Vinblastine Sulfate bulk with WC offered by CIPLA LTD

    Find a price of Vincristine Sulfate bulk with WC offered by CIPLA LTD

    Find a price of Vortioxetine Hydrobromide bulk with DMF, WC offered by CIPLA LTD

    Find a price of Albendazole bulk with WC offered by CIPLA LTD

    Find a price of Amlodipine Mesylate bulk with WC offered by CIPLA LTD

    Find a price of Artemether bulk with WC offered by CIPLA LTD

    Find a price of Artesunate bulk with WC offered by CIPLA LTD

    Find a price of Carboplatin bulk with CEP offered by CIPLA LTD

    Find a price of Citalopram Hydrobromide bulk with WC offered by CIPLA LTD

    Find a price of Lansoprazole bulk with CEP offered by CIPLA LTD

    Find a price of Levalbuterol Sulfate bulk with WC offered by CIPLA LTD

    Find a price of Lopinavir bulk with DMF offered by CIPLA LTD

    Find a price of Lumefantrine bulk with WC offered by CIPLA LTD

    Find a price of Oxaliplatin bulk with CEP offered by CIPLA LTD

    Find a price of Pregabalin bulk with WC offered by CIPLA LTD

    Find a price of Sorafenib bulk with WC offered by CIPLA LTD

    Find a price of Zidovudine bulk with DMF offered by CIPLA LTD

    Find a price of Abiraterone Acetate bulk with DMF offered by CIPLA LTD

    Find a price of Acalabrutinib bulk with DMF offered by CIPLA LTD

    Find a price of Albendazole bulk with DMF offered by CIPLA LTD

    Find a price of Alendronate Sodium bulk with WC offered by CIPLA LTD

    Find a price of Alfuzosin HCl bulk offered by CIPLA LTD

    Find a price of Alosetron Hydrochloride bulk with DMF offered by CIPLA LTD

    Find a price of Anagrelide Hydrochloride bulk with DMF offered by CIPLA LTD

    Find a price of Apixaban bulk with DMF offered by CIPLA LTD

    Find a price of Atazanavir Sulfate bulk with DMF offered by CIPLA LTD

    Find a price of Azelastine Hydrochloride bulk offered by CIPLA LTD

    Find a price of Bictegravir Sodium bulk with DMF offered by CIPLA LTD

    Find a price of Brexpiprazole bulk with DMF offered by CIPLA LTD

    Find a price of Budesonide bulk with CEP offered by CIPLA LTD

    Find a price of Cabotegravir bulk with DMF offered by CIPLA LTD

    Find a price of Cabotegravir Sodium bulk with DMF offered by CIPLA LTD

    Find a price of Capecitabine bulk offered by CIPLA LTD

    Find a price of CAS 103639-04-9 bulk with WC offered by CIPLA LTD

    Find a price of CAS 120011-70-3 bulk with WC offered by CIPLA LTD

    Find a price of CAS No 1613220-15-7 bulk with DMF offered by CIPLA LTD

    Find a price of Cetirizine bulk with WC offered by CIPLA LTD

    Find a price of Cetirizine Dihydrochloride bulk with WC offered by CIPLA LTD

    Find a price of Ciprofloxacin Hydrochloride bulk offered by CIPLA LTD

    Find a price of Cisplatin bulk with CEP offered by CIPLA LTD

    Find a price of Citalopram Hydrobromide bulk with DMF offered by CIPLA LTD

    Find a price of Daprodustat bulk with DMF offered by CIPLA LTD

    Find a price of Darunavir bulk with DMF offered by CIPLA LTD

    Find a price of Dasatinib bulk with DMF offered by CIPLA LTD

    Find a price of Deucravacitinib bulk with DMF offered by CIPLA LTD

    Find a price of Difelikefalin Acetate bulk with DMF offered by CIPLA LTD

    Find a price of Disodium Pamidronate Pentahydrate bulk offered by CIPLA LTD

    Find a price of Dolutegravir Sodium bulk with DMF offered by CIPLA LTD

    Find a price of Donepezil bulk with DMF offered by CIPLA LTD

    Find a price of Dutasteride bulk offered by CIPLA LTD

    Find a price of Edaravone bulk with DMF offered by CIPLA LTD

    Find a price of Emtricitabine bulk with WC offered by CIPLA LTD

    Find a price of Ensifentrine bulk with DMF offered by CIPLA LTD

    Find a price of Entecavir Monohydrate bulk with WC offered by CIPLA LTD

    Find a price of Enzalutamide bulk with DMF offered by CIPLA LTD

    Find a price of Esomeprazole Magnesium bulk with WC offered by CIPLA LTD

    Find a price of Etoposide bulk with WC offered by CIPLA LTD

    Find a price of Felodipine bulk with WC offered by CIPLA LTD

    Find a price of Fexofenadine Hydrochloride bulk offered by CIPLA LTD

    Find a price of Fluconazole bulk with DMF offered by CIPLA LTD

    Find a price of Fluticasone Furoate bulk with DMF offered by CIPLA LTD

    Find a price of Fluticasone Propionate bulk with CEP offered by CIPLA LTD

    Find a price of Gemcitabine bulk offered by CIPLA LTD

    Find a price of Icatibant Acetate bulk with DMF offered by CIPLA LTD

    Find a price of Indacaterol Acetate bulk with DMF offered by CIPLA LTD

    Find a price of Ipratropium Bromide bulk offered by CIPLA LTD

    Find a price of Irinotecan Hydrochloride bulk offered by CIPLA LTD

    Find a price of Isavuconazonium Sulfate bulk with DMF offered by CIPLA LTD

    Find a price of Ivabradine Hydrochloride bulk with WC offered by CIPLA LTD

    Find a price of Ivacaftor bulk with DMF offered by CIPLA LTD

    Find a price of Ixazomib Citrate bulk with DMF offered by CIPLA LTD

    Find a price of Leflunomide bulk with WC offered by CIPLA LTD

    Find a price of Lenalidomide bulk with DMF offered by CIPLA LTD

    Find a price of Levalbuterol Hydrochloride bulk with DMF offered by CIPLA LTD

    Find a price of Levofloxacin bulk with DMF offered by CIPLA LTD

    Find a price of Levofloxacin Hemihydrate bulk with WC offered by CIPLA LTD

    Find a price of Levonorgestrel bulk with DMF offered by CIPLA LTD

    Find a price of Linagliptin bulk with WC offered by CIPLA LTD

    Find a price of Losartan Potassium bulk offered by CIPLA LTD

    Find a price of Mirabegron bulk with DMF offered by CIPLA LTD

    Find a price of Mitoxantrone bulk offered by CIPLA LTD

    Find a price of Mometasone Furoate bulk with DMF offered by CIPLA LTD

    Find a price of Montelukast Sodium bulk with DMF offered by CIPLA LTD

    Find a price of Nateglinide bulk offered by CIPLA LTD

    Find a price of Nilotinib bulk with DMF offered by CIPLA LTD

    Find a price of Nirmatrelvir bulk with DMF offered by CIPLA LTD

    Find a price of Norfloxacin bulk offered by CIPLA LTD

    Find a price of Olaparib bulk with DMF offered by CIPLA LTD

    Find a price of Omeprazole Magnesium bulk with CEP offered by CIPLA LTD

    Find a price of Omeprazole Sodium bulk with WC offered by CIPLA LTD

    Find a price of Ondansetron bulk with WC offered by CIPLA LTD

    Find a price of Pantoprazole Sodium bulk with WC offered by CIPLA LTD

    Find a price of Pioglitazone Hydrochloride bulk with DMF offered by CIPLA LTD

    Find a price of Pirfenidone bulk with WC offered by CIPLA LTD

    Find a price of Pomalidomide bulk with DMF offered by CIPLA LTD

    Find a price of Potassium Dihydrogen Phosphate bulk with DMF offered by CIPLA LTD

    Find a price of Praziquantel bulk with WC offered by CIPLA LTD

    Find a price of Relugolix bulk with DMF offered by CIPLA LTD

    Find a price of Resmetirom bulk with DMF offered by CIPLA LTD

    Find a price of Revefenacin bulk with DMF offered by CIPLA LTD

    Find a price of Rilpivirine bulk with DMF offered by CIPLA LTD

    Find a price of Rilpivirine Hydrochloride bulk with DMF offered by CIPLA LTD

    Find a price of Risperidone bulk with WC offered by CIPLA LTD

    Find a price of Rivastigmine Tartrate bulk with WC offered by CIPLA LTD

    Find a price of Rizatriptan Benzoate bulk with DMF offered by CIPLA LTD

    Find a price of Ruxolitinib Phosphate bulk with DMF offered by CIPLA LTD

    Find a price of Salmeterol Xinafoate bulk with DMF offered by CIPLA LTD

    Find a price of Sertraline Hydrochloride bulk offered by CIPLA LTD

    Find a price of Siponimod bulk with DMF offered by CIPLA LTD

    Find a price of Sodium Thiosulfate bulk with DMF offered by CIPLA LTD

    Find a price of Sorafenib bulk with DMF offered by CIPLA LTD

    Find a price of Sumatriptan bulk offered by CIPLA LTD

    Find a price of Tafamidis bulk with DMF offered by CIPLA LTD

    Find a price of Telmisartan bulk with DMF offered by CIPLA LTD

    Find a price of Tenofovir Alafenamide Fumarate bulk with DMF offered by CIPLA LTD

    Find a price of Terbinafine Hydrochloride bulk with WC offered by CIPLA LTD

    Find a price of Ticagrelor bulk with WC offered by CIPLA LTD

    Find a price of Tolterodine Tartrate bulk with DMF offered by CIPLA LTD

    Find a price of Umeclidinium Bromide bulk with DMF offered by CIPLA LTD

    Find a price of UNII-B7XF2TD73C bulk with WC offered by CIPLA LTD

    Find a price of Vilanterol Trifenatate bulk with DMF offered by CIPLA LTD

    Find a price of Vinorelbine Tartrate bulk offered by CIPLA LTD

    Find a price of Zolpidem Tartrate bulk offered by CIPLA LTD

    Find a price of DIBASIC POTASSIUM PHOSPHATE USP bulk with DMF offered by CIPLA LTD

    Find a price of GLYCOPYRROLATE USP bulk with DMF offered by CIPLA LTD

    Find a price of Acyclovir bulk offered by CIPLA LTD

    Find a price of Adefovir Dipivoxil bulk offered by CIPLA LTD

    Find a price of Alprazolam bulk offered by CIPLA LTD

    Find a price of Androsterone bulk offered by CIPLA LTD

    Find a price of Aripiprazole bulk offered by CIPLA LTD

    Find a price of Bortezomib bulk offered by CIPLA LTD

    Find a price of Clonidine bulk offered by CIPLA LTD

    Find a price of Clopidogrel bulk offered by CIPLA LTD

    Find a price of Daclatasvir bulk offered by CIPLA LTD

    Find a price of Darunavir bulk offered by CIPLA LTD

    Find a price of Desloratadine bulk offered by CIPLA LTD

    Find a price of Didanosine bulk offered by CIPLA LTD

    Find a price of Donepezil bulk offered by CIPLA LTD

    Find a price of Doxazosin Mesylate bulk offered by CIPLA LTD

    Find a price of Drospirenone bulk offered by CIPLA LTD

    Find a price of Flutamide bulk offered by CIPLA LTD

    Find a price of Ibrutinib bulk offered by CIPLA LTD

    Find a price of Ibuprofen bulk offered by CIPLA LTD

    Find a price of Imatinib Mesylate bulk offered by CIPLA LTD

    Find a price of Imiquimod bulk offered by CIPLA LTD

    Find a price of Irbesartan bulk offered by CIPLA LTD

    Find a price of Lamivudine bulk offered by CIPLA LTD

    Find a price of Lorazepam bulk offered by CIPLA LTD

    Find a price of Metaproterenol Hemisulfate bulk offered by CIPLA LTD

    Find a price of Methocarbamol bulk offered by CIPLA LTD

    Find a price of Metoprolol Tartrate bulk offered by CIPLA LTD

    Find a price of Moxifloxacin Hydrochloride bulk offered by CIPLA LTD

    Find a price of Mycophenolate Mofetil bulk offered by CIPLA LTD

    Find a price of Nifedipine bulk offered by CIPLA LTD

    Find a price of Ofloxacin bulk offered by CIPLA LTD

    Find a price of Olanzapine bulk offered by CIPLA LTD

    Find a price of Olmesartan Medoxomil bulk offered by CIPLA LTD

    Find a price of Paliperidone bulk offered by CIPLA LTD

    Find a price of Perindopril Erbumine bulk offered by CIPLA LTD

    Find a price of Podophyllotoxin bulk offered by CIPLA LTD

    Find a price of Pomalidomide bulk offered by CIPLA LTD

    Find a price of Propranolol Hydrochloride bulk offered by CIPLA LTD

    Find a price of Quetiapine Hemifumarate bulk offered by CIPLA LTD

    Find a price of Rabeprazole Sodium bulk offered by CIPLA LTD

    Find a price of Raloxifene Hydrochloride bulk offered by CIPLA LTD

    Find a price of Ranolazine bulk offered by CIPLA LTD

    Find a price of Rosiglitazone Maleate bulk offered by CIPLA LTD

    Find a price of Salmeterol Xinafoate bulk offered by CIPLA LTD

    Find a price of Saxagliptin Hydrochloride bulk offered by CIPLA LTD

    Find a price of Sibutramine Hydrochloride bulk offered by CIPLA LTD

    Find a price of Stavudine bulk offered by CIPLA LTD

    Find a price of Tamsulosin bulk offered by CIPLA LTD

    Find a price of Temozolomide bulk offered by CIPLA LTD

    Find a price of Terbutaline Sulfate bulk offered by CIPLA LTD

    Find a price of Testosterone bulk offered by CIPLA LTD

    Find a price of Topotecan Hydrochloride bulk offered by CIPLA LTD

    Find a price of Torsemide bulk offered by CIPLA LTD

    Find a price of Trioxsalen bulk offered by CIPLA LTD

    Find a price of Valsartan bulk offered by CIPLA LTD

    Find a price of Zaleplon bulk offered by CIPLA LTD

    Find a price of Zoledronic Acid bulk offered by CIPLA LTD

    Find a price of FACILITIES, CONTROLS AND OPERATING PROC. AT BOMBAY, INDIA bulk offered by CIPLA LTD

    Find a price of FACILITIES, CONTROLS, AND OPERATING PROC. AT BANGALORE, INDIA bulk offered by CIPLA LTD

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN PATALGANGA, INDIA. bulk offered by CIPLA LTD

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN KURKUMBH, INDIA. bulk offered by CIPLA LTD

    Find a price of PROPANOLOL HCl bulk offered by CIPLA LTD

    Find a price of FACILITIES, CONTROLS, AND OPERATING PROC. AT VIKHROLI, INDIA bulk offered by CIPLA LTD

    Find a price of Amlodipine Besylate bulk offered by CIPLA LTD

    Find a price of Amlodipine Mesylate bulk offered by CIPLA LTD

    Find a price of Anagrelide Hydrochloride bulk offered by CIPLA LTD

    Find a price of Apalutamide bulk offered by CIPLA LTD

    Find a price of Apremilast bulk offered by CIPLA LTD

    Find a price of Axitinib bulk offered by CIPLA LTD

    Find a price of Baricitinib bulk offered by CIPLA LTD

    Find a price of Bictegravir bulk offered by CIPLA LTD

    Find a price of Celecoxib bulk offered by CIPLA LTD

    Find a price of Cetirizine Dihydrochloride bulk offered by CIPLA LTD

    Find a price of CID 69349199 bulk offered by CIPLA LTD

    Find a price of CID 9873495 bulk offered by CIPLA LTD

    Find a price of Crisaborole bulk offered by CIPLA LTD

    Find a price of Danazol bulk offered by CIPLA LTD

    Find a price of Deferasirox bulk offered by CIPLA LTD

    Find a price of Deferiprone bulk offered by CIPLA LTD

    Find a price of Dexlansoprazole bulk offered by CIPLA LTD

    Find a price of Docetaxel bulk offered by CIPLA LTD

    Find a price of Efinaconazole bulk offered by CIPLA LTD

    Find a price of Erlotinib Hydrochloride bulk offered by CIPLA LTD

    Find a price of Everolimus bulk offered by CIPLA LTD

    Find a price of Favipiravir bulk offered by CIPLA LTD

    Find a price of Felodipine bulk offered by CIPLA LTD

    Find a price of Fenbendazole bulk offered by CIPLA LTD

    Find a price of Finasteride bulk offered by CIPLA LTD

    Find a price of Fluconazole bulk offered by CIPLA LTD

    Find a price of Glatiramer Acetate bulk offered by CIPLA LTD

    Find a price of Glycopyrronium Bromide bulk offered by CIPLA LTD

    Find a price of Granisetron bulk offered by CIPLA LTD

    Find a price of Ibandronate Sodium bulk offered by CIPLA LTD

    Find a price of Lenalidomide bulk offered by CIPLA LTD

    Find a price of Lenvatinib bulk offered by CIPLA LTD

    Find a price of Levocetirizine Dihydrochloride bulk offered by CIPLA LTD

    Find a price of Lifitegrast bulk offered by CIPLA LTD

    Find a price of Meloxicam bulk offered by CIPLA LTD

    Find a price of Paclitaxel bulk offered by CIPLA LTD

    Find a price of Palbociclib bulk offered by CIPLA LTD

    Find a price of Pantoprazole Sodium bulk offered by CIPLA LTD

    Find a price of Pioglitazone bulk offered by CIPLA LTD

    Find a price of Pregabalin bulk offered by CIPLA LTD

    Find a price of Ribociclib bulk offered by CIPLA LTD

    Find a price of Risperidone bulk offered by CIPLA LTD

    Find a price of Sacubitril-Valsartan bulk offered by CIPLA LTD

    Find a price of Sitagliptin Hydrochloride bulk offered by CIPLA LTD

    Find a price of Sitagliptin Phosphate bulk offered by CIPLA LTD

    Find a price of Sofosbuvir bulk offered by CIPLA LTD

    Find a price of Sorafenib bulk offered by CIPLA LTD

    Find a price of Sugammadex Sodium bulk offered by CIPLA LTD

    Find a price of Topiramate bulk offered by CIPLA LTD

    Find a price of Vildagliptin bulk offered by CIPLA LTD

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search